Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.41 |
| ▸ | DRD4 | P21917 | 1/20 | 0.41 |
| ▸ | DRD3 | P35462 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | SLC18A3 | Q16572 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5601787 | 1.00 | DRD2 (0.41) | DRD2DRD4DRD3PKMSLC18A3 | |
| SCHEMBL5601758 | 1.00 | DRD2 (0.41) | DRD2DRD4DRD3PKMSLC18A3 | |
| SCHEMBL5600054 | 1.00 | DRD2 (0.41) | DRD2DRD4DRD3PKMSLC18A3 | |
| SCHEMBL5599984 | 1.00 | DRD2 (0.41) | DRD2DRD4DRD3PKMSLC18A3 | |
| SCHEMBL1901033 | 1.00 | DRD2 (0.41) | DRD2DRD4DRD3PKMSLC18A3 | |
| SCHEMBL5601528 | 1.00 | DRD2 (0.41) | DRD2DRD4DRD3PKMSLC18A3 | |
| SCHEMBL5602242 | 1.00 | DRD2 (0.41) | DRD2DRD4DRD3PKMSLC18A3 | |
| Hydrochloric Acid SCHEMBL27290402 | 0.97 | DRD2 (0.39) | DRD2DRD4DRD3PKMSLC18A3 | |
| SCHEMBL260416 | 0.97 | DRD2 (0.42) | DRD2DRD4DRD3PKMSLC18A3 | |
| SCHEMBL5603702 | 0.91 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12497560-B2 | Organic light-emitting device and apparatus including organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-12-16 | — | — | US | claimed |
| CN-110943176-A | Organic light emitting device and apparatus including the same | 三星显示有限公司 | 2020-03-31 | — | — | CN | claimed |
| US-20200098991-A1 | ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-03-26 | — | — | US | claimed |
| US-7276567-B2 | Heterocyclic substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-10-02 | — | — | US | claimed |
| US-12497560-B2 | Organic light-emitting device and apparatus including organic light-emitting device | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-12-16 | — | — | US | disclosed |
| US-20240415014-A1 | ORGANIC MOLECULE LIGHT EMITTERS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2024-12-12 | — | — | US | disclosed |
| EP-4021910-A1 | NEW THERAPEUTIC AGENTS FOR THE TREATMENT OF HAEMATOLOGICAL PATHOLOGIES | Universita' degli Studi di Palermo (IT) | 2022-07-06 | — | — | EP | disclosed |
| CN-110943176-A | Organic light emitting device and apparatus including the same | 三星显示有限公司 | 2020-03-31 | — | — | CN | disclosed |
| US-20200098991-A1 | ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-03-26 | — | — | US | disclosed |
| CN-101774998-A | 3-methyl-octahydro-cycloheptatriene oxapicene-2-ketone and preparation method thereof | SHANGHAI RES INST OF FRAGRANCE | 2010-07-14 | — | — | CN | disclosed |
| US-7276567-B2 | Heterocyclic substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2007-10-02 | — | — | US | disclosed |
| US-20050261449-A1 | Heterocyclic substituted metallocene compounds for olefin polymerization | EXXONMOBIL CHEMICAL PATENT INC. | 2005-11-24 | — | — | US | disclosed |
| US-20040186160-A1 | Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors | SUGEN, INC. | 2004-09-23 | — | — | US | disclosed |
| US-20040186160-A1 | Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors | SUGEN, INC. | 2004-09-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200098991-A1 | ORGANIC LIGHT-EMITTING DEVICE AND APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE | CRY1, CYBA, CRY2 | DRD2 2337/4885DRD4 2362/4885DRD3 2203/4885 |
| US-20240415014-A1 | ORGANIC MOLECULE LIGHT EMITTERS | CCND3, CCND2, OPRD1 | DRD2 33/4885DRD4 18/4885DRD3 23/4885 |
| US-12497560-B2 | Organic light-emitting device and apparatus including organic light-emitting device | CRY1, CYBA, CRY2 | DRD2 2337/4885DRD4 2362/4885DRD3 2203/4885 |
| US-20040186160-A1 | Hexahydro-cyclohepta-pyrrole oxindole as potent kinase inhibitors | MAP3K15, MAP3K20, MAP3K19 | DRD2 1339/4885DRD4 1868/4885DRD3 1685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.